Month: May 2022

Plan of Arrangement Approved by Orca Securityholders

Written by Customer Service on May 16, 2022. Posted in Mergers And Acquisitions.

PERTH, Western Australia, May 16, 2022 (GLOBE NEWSWIRE) — On February 28, 2022, Perseus Mining Limited (“Perseus”) (ASX/TSX:PRU) announced that it had entered into a definitive agreement with Orca Gold Inc. (“Orca”) (TSXV: ORG) to acquire all of the outstanding common shares of Orca not already owned by Perseus, by way of a statutory plan of arrangement under the Canada Business Corporations Act (the “Arrangement”). Perseus is pleased to announce that at a special meeting of Orca securityholders held on May 16, 2022 in Vancouver, Canada, Orca securityholders voted in favour of implementation of the Arrangement. The completion of the Arrangement remains subject to final approval by the TSX Venture Exchange and the Toronto Stock Exchange and the granting of the final court order by the Supreme Court of British Columbia at a hearing...

Dewmar International Announces the Public Availability of Its Disclosure Document and Its Financial Statement for the Quarter Ended March 31, 2022

Written by Customer Service on May 16, 2022. Posted in Earnings Releases And Operating Results.

NEW YORK, NY, May 16, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Dewmar International BMC Inc. announced today that its complete disclosure statements and financial reports for the quarter ended March 31, 2022 is available for download on its website. The file is not password protected and anyone can view the disclosure statements and financial statements by simply clicking on the download button. To view the complete reports, simply visit https://dewmarinternational.com and click on Financials on the top navigation row or click on the following link. https://dewmarinternational.com/financials This press release is not an offer to sell or a solicitation of an offer to buy securities. Donald Hunter, Chairman and Chief Executive Officer of Dewmar commented, “We are announcing this required information to be deemed to be providing...

Dada Announces Unaudited First Quarter 2022 Financial Results

Written by Customer Service on May 16, 2022. Posted in Earnings Releases And Operating Results.

SHANGHAI, China, May 16, 2022 (GLOBE NEWSWIRE) — Dada Nexus Limited (NASDAQ: DADA, “Dada” or the “Company”), China’s leading local on-demand delivery and retail platform, today announced its unaudited financial results for the first quarter ended March 31, 2022. First Quarter 2022 HighlightsTotal net revenues in the first quarter were RMB2,025.3 million. Total Gross Merchandise Volume (“GMV”) of JDDJ for the twelve months ended March 31, 2022 was RMB49.1 billion, an increase of 74.4% year over year from RMB28.1 billion in the same period of 2021. Number of active consumers for the twelve months ended March 31, 2022 was 67.9 million, as compared with 46.1 million in the same period of 2021.“We are proud of our results in the first quarter of 2022 and excited by the progress in our business, as we gain trust from more consumers,...

Euro Manganese Reports Shipment of the Final Demonstration Plant Modules

Written by Customer Service on May 16, 2022. Posted in Public Companies.

VANCOUVER, British Columbia, May 16, 2022 (GLOBE NEWSWIRE) — Euro Manganese Inc. (TSX-V and ASX: EMN; OTCQX: EUMNF; Frankfurt: E06) (the “Company” or “EMN“) is pleased to announce that the second and final consignment of the Company’s demonstration plant modules was shipped today by ocean freight from Shanghai, China to Hamburg, Germany. The first consignment was shipped on April 30. Upon arrival in Hamburg, each consignment will be delivered to the Chvaletice Manganese Project site by rail. Delivery is expected in June and July respectively, with assembly commencing on arrival of each consignment. Commissioning is targeted for September and first delivery of samples to customers expected in Q4 2022. About Euro Manganese Inc. Euro Manganese Inc. is a battery materials company focused on becoming a leading,...

OKYO Pharma Limited Announces Pricing of Public Offering and Nasdaq Listing

Written by Customer Service on May 16, 2022. Posted in Public Companies.

LONDON, May 16, 2022 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq: OKYO, LSE: OKYO) (“OKYO Pharma” or the “Company“), a biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and ocular pain, announced the pricing of an underwritten public offering of 625,000 American Depositary Shares (the “ADSs”) at a public offering price of $4.00 per ADS. In addition, OKYO Pharma has granted the underwriters a 45-day option to purchase up to an additional 93,750 ADSs to cover over-allotments, if any. The gross proceeds to the Company from this offering are expected to be approximately $2,500,000 before deducting underwriting discounts, commissions and other offering expenses, and excluding the exercise of the over-allotment option, if any. The offering is expected to close...

VERB Publishes Management’s Prepared Remarks During First Quarter 2022 Earnings Call

Written by Customer Service on May 16, 2022. Posted in Public Companies.

Q1 2022 SaaS Recurring Revenue Up 37% Over Q1 2021 Q1 2022 Gross Profit Up 31% Over Q1 2021 R&D Operational Costs Cut 45% from Q1 2021 MARKET LIVESTREAM SHOPPING FESTIVAL DATES SET – JULY 26, 27 & 28First quarter 2022 SaaS recurring revenue up 37% over prior year comparable quarter First quarter 2022 gross profit margin up 31% over prior year comparable quarter First quarter 2022 Total Digital revenue up 19% over prior year comparable quarter SaaS recurring revenue now accounts for 93% of Total Digital revenue – up from 81% in Q1 2021 SaaS recurring revenue now accounts for 74% of total revenue – up from 58% in Q1 2021 Total Digital revenue accounts for 80% of total revenue – up from 71% in Q1 2021 R&D expense down 45% from prior year comparable quarter and down 42% from Q4 2021 Modified EBITDA1 improvement by $1 million...

Acreage Announces Social Equity Partnership in Connecticut

Written by Customer Service on May 16, 2022. Posted in Public Companies.

Company enters into equity joint venture with medical cannabis advocate and CannaHealth™ founder Kebra Smith-Bolden NEW YORK, May 16, 2022 (GLOBE NEWSWIRE) — Acreage Holdings, Inc. (“Acreage” or the “Company”) (CSE: ACRG.A.U, ACRG.B.U), (OTC: ACRHF, ACRDF), a multi-state operator of cannabis ‎cultivation and retailing facilities in the U.S., today announced it will launch a social equity partnership with Kebra Smith-Bolden, a cannabis advocate and business owner based in Connecticut. Once approved by the state’s Social Equity Council, Acreage will support Smith-Bolden’s retail and cultivation operations in the Greater New Haven metropolitan area. Smith-Bolden is the founder of CannaHealth™, a leading medical cannabis certification provider and the first Black-owned cannabis business in Connecticut. Since 2017, CannaHealth™ has...

Titanium Transportation Group Reports Record $136 million Revenue and Adjusted EBITDA of $14 million in Q1 2022

Written by Customer Service on May 16, 2022. Posted in Earnings Releases And Operating Results.

BOLTON, Ontario, May 16, 2022 (GLOBE NEWSWIRE) — Titanium Transportation Group Inc. (“Titanium” or the “Company”) (TSXV:TTR), a leading provider of transportation and logistics services throughout North America, is pleased to report its financial results for the three month period ended March 31, 2022. All amounts are in Canadian currency. Q1 2022 Financial Highlights compared with Q1 2021Record consolidated revenue of $136.0 million — an increase of 58.7% Consolidated EBITDA(1) of $13.9 million — an increase of 85.2% — EBITDA Margin(1) of 11.5% Logistics segment revenue of $87.9 million — an increase of 84.9% — including US freight brokerage revenue of $54.9 million which increased 69.6% Logistics segment EBITDA of $9.2 million –EBITDA Margin of 11.5% Truck Transportation...

InterCure Begins 2022 with Record Breaking First Quarter Financial Results

Written by Customer Service on May 16, 2022. Posted in Earnings Releases And Operating Results.

Quarterly revenues Quarterly revenuesRecord revenue of $341 million in the first quarter of 2022 Adjusted EBITDA2 increased almost 110% year-over-year to $8 million Net income of $6 million for the Q1 of 2022 compared to $2 million in Q1 of 2021 Seventh consecutive quarter of positive cash flow from operations $91 million cash on March 31, 2022 Revenue growth expected to continue in the second quarter and throughout 2022 NEW YORK and TORONTO and HERZLIYA, Israel , May 16, 2022 (GLOBE NEWSWIRE) — InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)(“InterCure” or the “Company”) is pleased to announced its financial results for the first quarter of 2022 and is pleased to provide shareholders with a business update. All amounts are expressed in Canadian dollars ($)3 or New Israeli Shekels (NIS), unless...

ABVC Biopharma Reports First Quarter 2022 Financial and Operational Results

Written by Customer Service on May 16, 2022. Posted in Earnings Releases And Operating Results.

FREMONT, CA, May 16, 2022 (GLOBE NEWSWIRE) — via NewMediaWire—ABVC BioPharma, Inc. (Nasdaq: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced its financial and operating results for the first quarter of 2022. First Quarter 2022 Financial Results All comparisons are made on a year-over-year basis.Revenues. The Company generated $25,660 and $263,150 in revenues for the three months ended March 31, 2022 and 2021, respectively. The decrease in revenues was mainly due to the impact of COVID-19 on the Contract Development & Manufacturing Organization (“CDMO”) business sector. Operating Expenses increased by $4,727,835 to $6,242,485 for the three months ended March 31, 2022 from $1,514,650 for the three months ended March 31,...

Month: May 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals